Dublin, Sept. (GLOBE NEWSWIRE) -- "Collaboration Deals in Pharmaceuticals 2020-2026" has been added to ResearchAndMarkets.com's offering. The Collaboration Deals in Pharmaceuticals report delivers ...
Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2021-2026" has been added to ResearchAndMarkets.com's offering. The Manufacturing and ...
Hosted on MSN
Transformative trends in life sciences: The future of pharmaceuticals and biotechnology
The life sciences sector, encompassing pharmaceuticals, biotechnology, and medical devices, is experiencing unprecedented advancements driven by scientific innovation. Technologies such as artificial ...
Franklin Biotechnology Discovery Fund (Advisor Class without sales charges) outperformed Nasdaq Biotechnology Index in 2Q26 ...
December 2025 marked an exceptionally active period for life sciences regulation in the European Union (EU). Within the space of a few days, EU institutions have reached political agreement on the ...
DUBLIN--(BUSINESS WIRE)--The "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...
TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner’s 2025 Hype Cycle for Data Center Infrastructure Technologies LAS VEGAS--(BUSINESS ...
Eli Lilly and InnoCare Pharma inked a multi-target deal potentially worth $3.35 billion. The FDA has doled out the first approval for a novel cancer drug from a Korean company. | Eli Lilly and ...
In the ever-changing and fiercely competitive business landscape, conducting thorough company analysis is crucial for investors and industry experts. In this article, we will undertake a comprehensive ...
Frustrated by a slump that’s seen Europe lose ground to the U.S. and China, several top drugmakers are calling for speedier ...
This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Bell Linn: Welcome to Tech News Briefing. It's Friday, April 10th. I'm Bell Linn ...
How significant is FDA approval of Journavx for Vertex? Vertex CEO Reshma Kewalramani described the FDA approval of Journavx as "a historic milestone for the 80 million people in America who are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results